Prognostic Factors in Colorectal Liver Metastases: An Exhaustive Review of the Literature and Future Prospectives
Cancers · 31.07.2025 · 17 (15) · 2539
DOI: 10.3390/cancers17152539 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 31.07.2025. Verfasst von Maria Conticchio und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biology and Medicine, University of Lausanne, 1005 Lausanne, Switzerland. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 250 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Colorectal liver metastasis (CRLM) represents a major clinical challenge in oncology, affecting 25–50% of colorectal cancer patients and significantly impacting survival. While multimodal therapies—including surgical resection, systemic chemotherapy, and local ablative techniques—have improved outcomes, prognosis remains heterogeneous due to variations in tumor biology, patient factors, and institutional practices.
Methods
This review synthesizes current evidence on prognostic factors influencing CRLM management, encompassing clinical (e.g., tumor burden, anatomic distribution, timing of metastases), biological (e.g., CEA levels, inflammatory markers), and molecular (e.g., RAS/BRAF mutations, MSI status, HER2 alterations) determinants.
Results
Key findings highlight the critical role of molecular profiling in guiding therapeutic decisions, with RAS/BRAF mutations predicting resistance to anti-EGFR therapies and MSI-H status indicating potential responsiveness to immunotherapy. Emerging tools like circulating tumor DNA (ctDNA) and radiomics offer promise for dynamic risk stratification and early recurrence detection, while the gut microbiome is increasingly recognized as a modulator of treatment response.
Conclusions
Despite advancements, challenges persist in standardizing resectability criteria and integrating multidisciplinary approaches. Current guidelines (NCCN, ESMO, ASCO) emphasize personalized strategies but lack granularity in terms of incorporating novel biomarkers. This exhaustive review underscores the imperative for the development of a unified, biomarker-integrated framework to refine CRLM management and improve long-term outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Biology and Medicine, University of Lausanne, 1005 Lausanne, Switzerland.
- Department of Visceral Surgery, Centre Hospitalier Universitaire Vaudois (CHUV), 1005 Lausanne, Switzerland.
- Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), 1005 Lausanne, Switzerland.
- Department of Gastroenterology, Centre Hospitalier Universitaire Vaudois (CHUV), 1005 Lausanne, Switzerland.
- Department of Pathology, Centre Hospitalier Universitaire Vaudois (CHUV), 1005 Lausanne, Switzerland.
ORCID-Profile: Emilie Uldry, Martin Hübner, Antonia Digklia
Zitieren
APA
Conticchio, M., Uldry, E., Hübner, M., Digklia, A., Fraga, M., Sempoux, C., Raisaro, J. L., & Fuks, D. (2025). Prognostic Factors in Colorectal Liver Metastases: An Exhaustive Review of the Literature and Future Prospectives. Cancers, 17(15), 2539. https://doi.org/10.3390/cancers17152539
Vancouver
Conticchio M, Uldry E, Hübner M, Digklia A, Fraga M, Sempoux C, et al. Prognostic Factors in Colorectal Liver Metastases: An Exhaustive Review of the Literature and Future Prospectives. Cancers. 2025;17(15):2539. doi:10.3390/cancers17152539
BibTeX
@article{Conticchio2025,
author = {Conticchio, Maria and Uldry, Emilie and Hübner, Martin and Digklia, Antonia and Fraga, Montserrat and Sempoux, Christine and Raisaro, Jean Louis and Fuks, David},
title = {Prognostic Factors in Colorectal Liver Metastases: An Exhaustive Review of the Literature and Future Prospectives},
journal = {Cancers},
year = {2025},
volume = {17},
number = {15},
pages = {2539},
doi = {10.3390/cancers17152539}
}
EUVIMED